TransMedics Group (TMDX) Misses Q4 EPS by 4c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
TransMedics Group (TMDX) PT Lowered to $28 at Cowen
February 24, 2022 6:56 AM ESTCowen analyst Joshua Jennings lowered the price target on TransMedics Group (NASDAQ: TMDX) to $28.00 (from $29.00) while maintaining an Outperform rating.
The analyst commented, "TMDX reported 4Q sales of $9.7M, up 27%, vs the $7.5M consensus. It introduced 2022 sales guidance of $49M-$55M, reflecting... More
